The Abbvie shows a gross margin of 71.5%, an operating margin of 26.2%, an EBITDA margin of 29.8%, and a net margin of 9.8%. Operating margin drove the improvement across the available margins, increasing by 7.4 percentage points.
Over the last 3 years, Abbvie's margins averaged 68.04% gross, 21.56% operating, 27.81% EBITDA, and 7.89% net. All four current margins are above their three-year averages.
The biggest expansion was in operating margin, which rose by 7.4 percentage points. The other available margins also improved.
Throughout the last 3 years, Abbvie had an average gross margin of 68.04%. Against its three-year average, Abbvie's gross margin is currently 71.5%, 3.5 percentage points above its three-year average. Looking back over the last 3 years, Abbvie's gross margin reached 71.5% at its highest point in Jun 2026 and 62.3% at its lowest in Mar 2024.
Over the last 3 years, Abbvie's operating margin averaged 21.56%. The current operating margin of 26.2% is 4.6 percentage points above its three-year average. During this period, operating margin reached a high of 26.2% in Jun 2026 and a low of 15.2% in Sep 2025.
Looking at the last 3 years, Abbvie had an average EBITDA margin of 27.81%. As of the latest period, Abbvie's current EBITDA margin is 29.8%, which is 2 percentage points above its three-year average. Looking back over the last 3 years, Abbvie's EBITDA margin reached 32.8% at its highest point in Mar 2024 and 20.9% at its lowest in Sep 2025.
Across the last 3 years, Abbvie's net margin came to 7.89%. The current net margin stands at 9.8%, 1.9 percentage points above its three-year average. Net margin was highest at 11% in Mar 2024 and lowest at 4% in Sep 2025.
With a gross margin of 71.5%, ABBV is above the Healthcare sector and the industry average but below its peers average. But compared to its Healthcare sector average of 68.4%, Abbvie's gross margin is only 4.5% higher.
For the period ending Jun 30, 2026, ABBV recorded a gross margin of 71.5%.
For the period ending Jun 30, 2026, ABBV recorded an operating margin of 26.2%.
As of Jun 30, 2026, ABBV has an EBITDA margin of 29.8%.
The current net margin for ABBV is 9.8% as of Jun 30, 2026.
Over the past 3 years, ABBV reported average margins of 68.0% gross, 21.6% operating, 27.8% EBITDA, and 7.9% net.
In the last 5 years, the highest margins reported by ABBV were 71.5% gross in Jun 2026, 32.7% operating in Mar 2022, 43.6% EBITDA in Sep 2022, and 23.2% net in Sep 2022.
Abbvie's lowest recorded margins during the past 5 years were 62.3% gross in Mar 2024, 15.2% operating in Sep 2025, 20.9% EBITDA in Sep 2025, and 4% net in Sep 2025.